Quarterly Call Option Transactions in Cerevel Therapeutics Holdings, Inc. (CERE)
This table provides information about the institutional ownership of Cerevel Therapeutics Holdings, Inc. (CERE) during . The information is specifically focused on institutions that hold call options of Cerevel Therapeutics Holdings, Inc..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q2 2021 | 0 | 204,599 | 204,599 | — | 204,599 | |||
| Q3 2021 | 60,700 | 144,400 | 205,100 | 17,600 | 64,099 | 81,699 | 123,401 | |
| Q4 2021 | 57,800 | 12,500 | 70,300 | 75,900 | 10,000 | 85,900 | -15,600 | |
| Q1 2022 | 15,300 | 20,500 | 35,800 | 129,200 | 12,500 | 141,700 | -105,900 | |
| Q2 2022 | 68,500 | 78,400 | 146,900 | 0 | 20,700 | 20,700 | 126,200 | |
| Q3 2022 | 129,600 | 17,100 | 146,700 | 20,700 | 0 | 20,700 | 126,000 | |
| Q4 2022 | 25,100 | 180,300 | 205,400 | 37,500 | 0 | 37,500 | 167,900 | |
| Q1 2023 | 116,900 | 0 | 116,900 | 26,600 | 15,000 | 41,600 | 75,300 | |
| Q2 2023 | 24,800 | 7,500 | 32,300 | 65,100 | 0 | 65,100 | -32,800 | |
| Q3 2023 | 22,500 | 23,800 | 46,300 | 70,600 | 0 | 70,600 | -24,300 | |
| Q4 2023 | 564,200 | 469,300 | 1,033,500 | — | 1,033,500 | |||
| Q1 2024 | 61,000 | 61,500 | 122,500 | 157,000 | 0 | 157,000 | -34,500 | |
| Q2 2024 | 240,300 | 1,031,500 | 1,271,800 | 1,000 | 0 | 1,000 | 1,270,800 | |